From: Role of disturbed fatty acids metabolism in the pathophysiology of diabetic erectile dysfunction
Fatty Acids (nomenclature) | Name | Patients with VED (%) (n = 72) | Patients w/o VED (%) (n = 78) | Controls (%) (n = 88) |
---|---|---|---|---|
C12: 0 | Lauric acid | 0.21 ± 0.12 | 0.19 ± 0.11 | 0.21 ± 0.13 |
C13: 0 | Tridecylic acid | 0.79 ± 0.53** | 0.47 ± 0.45 | 0.53 ± 0.35 |
C14: 0 | Myristic acid | 4.12 ± 2.50*** | 3.03 ± 2.09* | 2.57 ± 2.30 |
C15: 0 | Pentadecylic acid | 1.07 ± 0.69*** | 0.75 ± 0.45* | 0.63 ± 0.51 |
C16: 0 | Palmitic acid | 28.82 ± 5.75** | 29. 25 ± 6.66** | 25.87 ± 4.16 |
C18: 0 | Stearic acid | 11.93 ± 5.82*** | 13.29 ± 5.18* | 14.88 ± 5.15 |
C20: 0 | Arachidic acid | 0.24 ± 0.32 | 0.23 ± 0.13* | 0.26 ± 0.31 |
C22: 0 | Behenic acid | 0.43 ± 0.41*** | 0.35 ± 0.16** | 0.27 ± 0.21 |
C23: 0 | Tricosylic acid | 0.59 ± 0.42 | 0.44 ± 0.28 | 0.60 ± 0.79 |
C24: 0 | Lignoceric acid | 2.06 ± 0.83** | 1.75 ± 1.14 | 1.42 ± 1.19 |
C26: 0 | Cerotic acid | 5.47 ± 2.28*** | 3.21 ± 3.05** | 3.72 ± 2.81 |
Σ SFA | 55.70 ± 9.4** | 52.84 ± 7.1 | 51,01 ± 8.7 | |
C14:1 cis-9 (n-5) | Myristoleic acid | 1.33 ± 0.71** | 0.98 ± 0.44*** | 1.60 ± 0.56 |
C16:1 cis-9 (n-7) | Palmitoleic acid | 0.56 ± 0.51 | 0.60 ± 0.54 | 0.57 ± 0.47 |
C18:1 cis-9 (n-9) | Oleic acid | 10.96 ± 4.18*** | 13.14 ± 3.31* | 14.53 ± 3.65 |
C18:1 cis 11(n-7) | Vaccenic acid | 1.31 ± 0.30 | 1.39 ± 0.38 | 1.47 ± 0.49 |
C20:1 cis11 (n-9) | Eicosenoic acid | 0.16 ± 0.13*** | 0.22 ± 0.18* | 0.26 ± 0.17 |
C22:1 cis13(n-9) | Erucic acid | 0.45 ± 0.21 | 0.50 ± 0.21 | 0.54 ± 0.87 |
C24:1 (n-9) | Nervonic acid | 1.70 ± 0.59*** | 1.61 ± 0.97*** | 3.00 ± 1.31 |
Σ MUFA | 16.50 ± 4.12*** | 18.43 ± 3.65*** | 21.00 ± 3.88 | |
Omega 3 family (n-3) | ||||
C18:3 cis9,12,15 | α-linolenic acid | 0.66 ± 0.34*** | 0.63 ± 0.27*** | 0.51 ± 0.28 |
C20:3 cis11,14,17 | Eicosatrienoic acid | 1.43 ± 0.48 | 1.80 ± 0.83* | 1.61 ± 0.95 |
C20:5 EPA | Eicosapentaenoic acid | 0.52 ± 0.26*** | 1.26 ± 1.02 | 1.54 ± 1.92 |
C22:6 DHA | Docosahexaenoic acid | 2.00 ± 1.39*** | 2.27 ± 1,21*** | 3.13 ± 1.20 |
Omega 6 family (n-6) | ||||
C18:2 cis9,12 | Linoleic acid | 12.05 ± 4.46*** | 10.40 ± 3.20** | 9.40 ± 5.21 |
C18:3 cis6,9,12 | γ-linolenic acid | 0.16 ± 0.17* | 0.19 ± 0.14 | 0.17 ± 0.11 |
C20:3 cis8,11,14 | Dihomo-γlinolenic acid | 0.18 ± 0.09*** | 0.28 ± 0.16 | 0.38 ± 0.27 |
C20:4 | Arachidonic acid | 10.75 ± 3.09* | 11.43 ± 2.38*** | 9.25 ± 3.36 |
Σ PUFA | 27.79 ± 5.06 | 28.42 ± 4.11 | 26.03 ± 5.85 | |
Σ UFA | 44.30 ± 5.75** | 47.16 ± 6.03 | 47.03 ± 6.75 | |
Desaturation index | ||||
C20:4/C20:3 (Δ5D) | 77.03 ± 51.26*** | 54.18 ± 40.75* | 47.99 ± 43.92 | |
C18:3/C18:2n-6 (Δ6D) | 0.015 ± 0.016** | 0.020 ± 0.015 | 0.023 ± 0.021 | |
C16:1/C16:0 (Δ9D-16) | 0.02 ± 0.02 | 0.02 ± 0.02 | 0.02 ± 0.01 | |
C18:1/C18:0 (Δ9D-18) | 1.18 ± 0.87 | 1.17 ± 0.66 | 1.17 ± 0.71 | |
C24:1/C18:1 | 0.18 ± 0.11* | 0.12 ± 0.08*** | 0.22 ± 0.12 | |
C18:0/C16:0 | 0.41 ± 0.21*** | 0.48 ± 0.21** | 0.57 ± 0.17 |